ADTX - Aditxt, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.48 0.0 (-0.54%)	0.0 (0.0%)	0.01 (2.52%)	0.01 (1.35%)	0.0 (-0.54%)	0.05 (10.74%)	-0.04 (-7.26%)	-0.04 (-7.18%)

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -3.45
Diluted EPS:: -3.45
Basic P/E:: -0.139
Diluted P/E:: -0.139
RSI(14) 1m:: 83.57
VWAP:: 0.48
RVol:: 0.0759

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.46 -0.01 (-2.14%)	Oct 15 16:18
1m	Price decrease 1m	0.46 -0.01 (-2.14%)	Oct 15 16:18
1m	Price decrease 1m	0.46 -0.01 (-2.14%)	Oct 15 16:18
1m	Price decrease 1m	0.46 -0.01 (-2.14%)	Oct 15 16:18
1m	Price decrease 1m	0.46 -0.01 (-2.14%)	Oct 15 16:18